NCT05867004View on ClinicalTrials.gov

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

July 3, 2025

Study Completion Date

December 31, 2026

Conditions

MelanomaImmune DefectTumor Skin

Trial Locations (1)

31059

RECRUITING

Institut Claudius Regaud, Toulouse

All Listed Sponsors

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Institut Claudius Regaud

OTHER